Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease

Laryngoscope

Volumn 122, Issue 1, 2012, Pages 204-211

  Shea, Paul F ^a   Richey, Phyllis A ^b   Wan, Jim Y ^b   Stevens, Suzanne R ^c  

^a Shea Ear Clinic   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

aminoglycoside; gentamicin; Meniere's; perfusion; streptomycin

Indexed keywords

DEXAMETHASONE; DEXAMETHASONE PLUS STREPTOMYCIN; STREPTOMYCIN; UNCLASSIFIED DRUG;

ADULT; AGED; AUDIOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH SURVEY; HEARING; HEARING LOSS; HUMAN; INNER EAR; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; TREATMENT OUTCOME; WORD RECOGNITION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MENIERE DISEASE; MIDDLE AGED; PERFUSION; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; STREPTOMYCIN; YOUNG ADULT;

EID: 84255204896     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.22362     Document Type: Review

References (47)

1. Helling K, Schonfeld U, Clarke AH,. Treatment of Meniere's disease by low-dosage intratympanic gentamicin application: effect on otolith function. Laryngoscope 2007; 117: 2244-2250. (Pubitemid 351339604)
2. Ruckenstein MJ, Rutka JA, Hawke M,. The treatment of Meniere's disease: Torok revisited. Laryngoscope 1991; 101: 211-218.
3. Hu A, Parnes LS,. 10-year review of endolymphatic sac surgery for intractable meniere disease. J Otolaryngol Head Neck Surg 2010; 39: 415-421.
4. Lee L, Pensak ML,. Contemporary role of endolymphatic mastoid shunt surgery in the era of transtympanic perfusion strategies. Ann Otol Rhinol Laryngol 2008; 117: 871-875.
5. Thomsen J, Bretlau P, Tos M, Johnsen NJ,. Placebo effect in surgery for Meniere's disease. A double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol 1981; 107: 271-277. (Pubitemid 11111585)
6. Bretlau P, Thomsen J, Tos M, Johnsen NJ,. Placebo effect in surgery for Meniere's disease: nine-year follow-up. Am J Otol 1989; 10: 259-261. (Pubitemid 19204764)
7. Hillman TA, Chen DA, Arriaga MA,. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease. Laryngoscope 2004; 114: 216-222. (Pubitemid 38182614)
8. Shea JJ Jr,. The role of dexamethasone or streptomycin perfusion in the treatment of Meniere's disease. Otolaryngol Clin North Am 1997; 30: 1051-1059.
9. Parnes LS, Sun AH, Freeman DJ,. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999; 109 (7 pt 2): 1-17. (Pubitemid 29315126)
10. Garduno-Anaya MA, Couthino De Toledo H, Hinojosa-Gonzalez R, Pane-Pianese C, Rios-Castaneda LC,. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 2005; 133: 285-294. (Pubitemid 41125682)
11. Shea JJ, Ge X,. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere's disease. Otolaryngol Clin North Am 1996: 353-358. (Pubitemid 26138064)
12. Silverstein H, Isaacson JE, Olds MJ, Rowan PT, Rosenberg S,. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial. Am J Otol 1998; 19: 196-201. (Pubitemid 28152576)
13. Blakley BW,. Update on intratympanic gentamicin for Meniere's disease. Laryngoscope 2000; 110 (2 pt 1): 236-240. (Pubitemid 30090854)
14. Light JP, Silverstein H, Jackson LE,. Gentamicin perfusion vestibular response and hearing loss. Otol Neurotol 2003; 24: 294-298. (Pubitemid 36337145)
15. Magnusson M, Padoan S,. Delayed onset of ototoxic effects of gentamicin in treatment of Meniere's disease. Rationale for extremely low dose therapy. Acta Otolaryngol 1991; 111: 671-676.
16. Kyrodimos E, Aidonis I, Sismanis A,. Hearing results following intratympanic gentamicin perfusion for Meniere's disease. J Laryngol Otol 2009; 123: 379-382.
17. Equilibrium CoHa,. Committee on Hearing and Eqilibrium Guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolarngol Head Neck Surg 1995 (113): 181-185.
18. Kinney SE, Sandridge SA, Newman CW,. Long-term effects of Meniere's disease on hearing and quality of life. Am J Otol 1997; 18: 67-73. (Pubitemid 27057795)
19. Anderson JP, Harris JP,. Impact of Meniere's disease on quality of life. Otol Neurotol 2001; 22: 888-894. (Pubitemid 33101342)
20. Yardley L, Dibb B, Osborne G,. Factors associated with quality of life in Meniere's disease. Clin Otolaryngol Allied Sci 2003; 28: 436-441. (Pubitemid 37188160)
21. Banerjee AS, Johnson IJ,. Intratympanic gentamicin for Meniere's disease: effect on quality of life as assessed by Glasgow benefit inventory. J Laryngol Otol 2006; 120: 827-831. (Pubitemid 44702029)
22. Kato BM, LaRouere MJ, Bojrab DI, Michaelides EM,. Evaluating quality of life after endolymphatic sac surgery: The Meniere's Disease Outcomes Questionnaire. Otol Neurotol 2004; 25: 339-344. (Pubitemid 39079818)
23. Jung J, Chun J, Kim N, Kim Y, Lee WS,. Evaluation of quality of life after intratympanic streptomycin injection in patients with Meniere's disease. Otol Neurotol 2008; 29: 816-823.
24. Diaz RC, LaRouere MJ, Bojrab DI, Zappia JJ, Sargent EW, Shaia WT,. Quality-of-life assessment of Meniere's disease patients after surgical labyrinthectomy. Otol Neurotol 2006; 28: 74-86.
25. Ge X, Shea JJ Jr,. Transtympanic electrocochleography: a 10-year experience. Otol Neurotol 2002; 23: 799-805.
26. Schwaber MK,. Transtympanic gentamicin perfusion for the treatment of Meniere's disease. Otolaryngol Clin North Am 2002; 35: 287-295, vi. (Pubitemid 34760221)
27. Fowler EP,. Streptomycin treatment of vertigo. Trans Am Acad Opthamol Otolaryngol 1948; 52: 293-301.
28. Hawkins JE, Lurie MH,. The ototoxicity of streptomycin. Ann Otol Rhinol Laryngol 1952; 61: 789-809.
29. Schuknect HF,. Ablation therapy in the management of Meniere's disease. Acta Otolaryngol Suppl 1957; 132: 1-42.
30. Beck C, Schmidt CL,. 10 years experience with intratympanally applied streptomycin (gentamycin) in the therapy of Morbus Meniere. Arch Otorhinolaryngol 1978; 221: 149-152. (Pubitemid 9027145)
31. Shea JJ, Norris CH,. Streptomycin perfusion of the labyrinth. Acta Otolaryngol Suppl 1991; 485: 123-130.
32. Nedzelski JM, Schessel DA, Bryce GE, Pfleiderer AG,. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Meniere's disease. Am J Otol 1992; 13: 18-22.
33. Minor LB,. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Am J Otol 1999; 20: 209-219. (Pubitemid 29476649)
34. Silverstein H, Hyman SM, Feldbaum J, Silverstein D,. Use of streptomycin sulfate in the treatment of Meniere's disease. Otolaryngol Head Neck Surg 1984; 92: 229-232. (Pubitemid 14128125)
35. Silverstein H, Arruda J, Rosenberg SI, Deems D, Hester TO,. Direct round window membrane application of gentamicin in the treatment of Meniere's disease. Otolaryngol Head Neck Surg 1999; 120: 649-655. (Pubitemid 29226249)
36. Beck C,. Intratympanic application of gentamicin for treatment of Meniere's disease. Keio J Med 1986; 35: 36-41.
37. Lalwani AK, McGuire JF,. Pharmacologic treatment of the cochlea and labyrinth. In:, Cummings CW, ed. Cummings Otolaryngology Head & Neck Surgery. 4th ed. Philadelphia, PA: Elsevier Mosby; 2005: 2944-2976.
38. Wanamaker HH, Gruenwald L, Damm KJ, Ogata Y, Slepecky N,. Dose-related vestibular and cochlear effects of transtympanic gentamicin. Am J Otol 1998; 19: 170-179. (Pubitemid 28152573)
39. Kimura RS, Iverson NA, Southard RE,. Selective lesions of the vestibular labyrinth. Ann Otol Rhinol Laryngol 1988; 97 (6 pt 1): 577-584. (Pubitemid 19021492)
40. Tran BA, Huy P, Deffrennes D,. Aminoglycoside binding sites in the inner ears of guinea pigs. Antimicrob Agents Chemother 1988; 32: 467-472. (Pubitemid 18089348)
41. Aran JM,. Current perspectives on inner ear toxicity. Otolaryngol Head Neck Surg 1995; 112: 133-144.
42. Norris CH, Aubert A, Shea JJ,. Comparison of cochleotoxicity and vestibulotoxicity of streptomycin and gentamicin. Meniere's Disease: Perspectives in the '90s, pp 485-490. Proceedings of the Third International Symposium on Meniere's Disease. Rome, Italy, October 20-23, 1993. Amsterdam/New York: Kugler Publications, 1994.
43. Chia SH, Gamst AC, Anderson JP, Harris JP,. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol 2004; 25: 544-552. (Pubitemid 39079778)
44. Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G, Rutka JA,. Intratympanic gentamicin for Meniere's disease: a meta-analysis. Laryngoscope 2004; 114: 2085-2091. (Pubitemid 39602470)
45. Light JP, Silverstein H,. Transtympanic perfusion: indications and limitations. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 378-383. (Pubitemid 39287563)
46. Shea JJ Jr,. Classification of Meniere's disease. Am J Otol 1993; 14: 224-229. (Pubitemid 23155871)
47. Silverstein H, Smouha E, Jones R,. Natural history vs. surgery for Meniere's disease. Otolaryngol Head Neck Surg 1989; 100: 6-16. (Pubitemid 19046900)